Macquarie Group LTD Sangamo Therapeutics, Inc Transaction History

Macquarie Group LTD

$83.5 Billion
Q3 2025

A detailed history of Macquarie Group LTD transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Macquarie Group LTD holds 400,000 shares of SGMO stock, worth $176,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400,000

Previous 400,000 -0.0%

Holding current value

$176,000

Previous $216,000 24.07%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $2,454 - $8,435	-7,669 Reduced 1.88%	400,000 $344,000
Q2 2024 Aug 09, 2024	BUY	$0.36 - $0.65 $2,760 - $4,984	7,669 Added 1.92%	407,669 $146,000
Q4 2022 Feb 21, 2023	SELL	$2.77 - $5.07 $720 - $1,318	-260 Reduced 0.06%	400,000 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $8,006 - $11,981	-1,875 Reduced 0.47%	400,260 $1.97 Million
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $9,925 - $12,336	-976 Reduced 0.24%	402,135 $4.81 Million

Q1 2021 May 14, 2021	BUY	$10.88 - $17.05 $19,910 - $31,201	1,830 Added 0.46%	403,111 $5.05 Million
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $30,363 - $40,397	-3,237 Reduced 0.8%	401,281 $3.79 Million
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $28,056 - $53,447	4,518 Added 1.13%	404,518 $3.62 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $2.49 Million - $3.71 Million	285,000 Added 247.83%	400,000 $4.31 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $472,062 - $783,305	61,148 Added 113.55%	115,000 $1.1 Million
Q4 2018 Feb 15, 2019	BUY	$9.51 - $16.6 $13,314 - $23,240	1,400 Added 2.67%	53,852 $618,000
Q3 2018 Nov 15, 2018	SELL	$13.05 - $19.05 $43,195 - $63,055	-3,310 Reduced 5.94%	52,452 $889,000
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $308,524 - $439,480	22,196 Added 66.13%	55,762 $792,000
Q1 2018 May 11, 2018	BUY	$16.7 - $26.35 $224,882 - $354,829	13,466 Added 67.0%	33,566 $638,000
Q4 2017 Feb 15, 2018	BUY	$11.6 - $17.35 $212,280 - $317,505	18,300 Added 1016.67%	20,100 $330,000
Q3 2017 Nov 08, 2017	BUY	$8.4 - $15.0 $15,120 - $27,000	1,800	1,800 $27,000

Others Institutions Holding SGMO

# of Institutions

124

Shares Held

62.5M

Call Options Held

953K

Put Options Held

1.11M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Sangamo Therapeutics, Inc Transaction History